Bank of America’s Enlivex Therapeutics ENLV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41K | Buy |
3,044
+2,824
| +1,284% | +$3.16K | ﹤0.01% | 6317 |
|
|
2025
Q1 | $213 | Sell |
220
-834
| -79% | -$807 | ﹤0.01% | 6619 |
|
|
2024
Q4 | $1.23K | Buy |
1,054
+909
| +627% | +$1.06K | ﹤0.01% | 6330 |
|
|
2024
Q3 | $244 | Buy |
+145
| New | +$244 | ﹤0.01% | 6592 |
|
|
2024
Q1 | – | Sell |
-266
| Closed | -$718 | – | 6864 |
|
|
2023
Q4 | $718 | Sell |
266
-572
| -68% | -$1.54K | ﹤0.01% | 6272 |
|
|
2023
Q3 | $1.32K | Hold |
838
| – | – | ﹤0.01% | 6272 |
|
|
2023
Q2 | $2.2K | Hold |
838
| – | – | ﹤0.01% | 6237 |
|
|
2023
Q1 | $3.05K | Buy |
838
+191
| +30% | +$695 | ﹤0.01% | 6333 |
|
|
2022
Q4 | $2.55K | Sell |
647
-103
| -14% | -$405 | ﹤0.01% | 6365 |
|
|
2022
Q3 | $3K | Sell |
750
-465
| -38% | -$1.86K | ﹤0.01% | 6619 |
|
|
2022
Q2 | $5K | Sell |
1,215
-4,948
| -80% | -$20.4K | ﹤0.01% | 6747 |
|
|
2022
Q1 | $34K | Buy |
6,163
+2,867
| +87% | +$15.8K | ﹤0.01% | 6522 |
|
|
2021
Q4 | $21K | Sell |
3,296
-389
| -11% | -$2.48K | ﹤0.01% | 6635 |
|
|
2021
Q3 | $36K | Buy |
3,685
+2,788
| +311% | +$27.2K | ﹤0.01% | 6288 |
|
|
2021
Q2 | $8K | Sell |
897
-2,238
| -71% | -$20K | ﹤0.01% | 6521 |
|
|
2021
Q1 | $35K | Buy |
3,135
+12
| +0.4% | +$134 | ﹤0.01% | 6048 |
|
|
2020
Q4 | $26K | Buy |
+3,123
| New | +$26K | ﹤0.01% | 5755 |
|
|
2020
Q1 | – | Sell |
-28
| Closed | – | – | 6232 |
|
|
2019
Q4 | $0 | Buy |
+28
| New | – | ﹤0.01% | 6272 |
|